Trial Outcomes & Findings for Mindful Minds: Mindfulness-Based Neurofeedback for Underrepresented College Students (NCT NCT06784934)

NCT ID: NCT06784934

Last Updated: 2026-08-04

Results Overview

Trier Social Stress Test will be utilized to induce performance anxiety through a mock job interview and mental arithmetic task conducted in front of a non-responsive committee at baseline and the final session (after 4 weeks). This test uses a standardized protocol that not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario. The social stress test not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

39 participants

Primary outcome timeframe

Final session at 4 weeks

Results posted on

2026-08-04

Participant Flow

Participant recruitment occurred from January 6, 2025, through March 25, 2025. Multiple recruitment strategies were utilized to reach potential participants. These included the distribution of IRB-approved flyers across campus and community locations, targeted social media posts, and in-class announcements. These combined methods were used to maximize visibility and engagement with eligible participants throughout the recruitment period.

A total of 59 individuals expressed interest in the study. Of these, 21 were excluded prior to assignment: 5 did not meet inclusion criteria, 14 declined to participate, and 2 were excluded for other reasons. The remaining eligible participants were assigned to study groups.

Participant milestones

Participant milestones
Measure
Mindfulness Neurofeedback
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Overall Study
STARTED
19
19
Overall Study
COMPLETED
18
16
Overall Study
NOT COMPLETED
1
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Mindfulness Neurofeedback
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Overall Study
Lost to Follow-up
1
2
Overall Study
Withdrawal by Subject
0
1

Baseline Characteristics

Analysis includes all participants with baseline PHQ-9 data; no exclusions.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mindfulness Neurofeedback
n=19 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=19 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Total
n=38 Participants
Total of all reporting groups
Age, Continuous
21.88 years
STANDARD_DEVIATION 2.39 • n=20 Participants
22.25 years
STANDARD_DEVIATION 2.84 • n=20 Participants
22.06 years
STANDARD_DEVIATION 2.58 • n=40 Participants
Sex: Female, Male
Female
13 Participants
n=20 Participants
16 Participants
n=20 Participants
29 Participants
n=40 Participants
Sex: Female, Male
Male
6 Participants
n=20 Participants
3 Participants
n=20 Participants
9 Participants
n=40 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Asian
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=20 Participants
5 Participants
n=20 Participants
10 Participants
n=40 Participants
Race (NIH/OMB)
White
11 Participants
n=20 Participants
13 Participants
n=20 Participants
24 Participants
n=40 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=20 Participants
1 Participants
n=20 Participants
4 Participants
n=40 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants
n=20 Participants
12 Participants
n=20 Participants
27 Participants
n=40 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants
n=20 Participants
7 Participants
n=20 Participants
11 Participants
n=40 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Patient Health Questionnaire-9 (PHQ-9)
5.26 scores on a scale
STANDARD_DEVIATION 4.66 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
5.42 scores on a scale
STANDARD_DEVIATION 3.39 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
5.34 scores on a scale
STANDARD_DEVIATION 4.04 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
Beck Anxiety Inventory
31.63 scores on a scale
STANDARD_DEVIATION 8.36 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
35.16 scores on a scale
STANDARD_DEVIATION 12.20 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
33.39 scores on a scale
STANDARD_DEVIATION 10.48 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
Academic Anxiety Scale
17.58 scores on a scale
STANDARD_DEVIATION 5.78 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
20.16 scores on a scale
STANDARD_DEVIATION 4.74 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
18.87 scores on a scale
STANDARD_DEVIATION 5.42 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
Total Correct Responses on the Verbal Mental Arithmetic Task
7.0 Responses
STANDARD_DEVIATION 5.54 • n=20 Participants
7.63 Responses
STANDARD_DEVIATION 7.37 • n=20 Participants
7.32 Responses
STANDARD_DEVIATION 6.44 • n=40 Participants

PRIMARY outcome

Timeframe: Final session at 4 weeks

Population: Participants were included if they completed the study and had initial and final verbal mental arithmetic task data. One mindfulness neurofeedback participant and three BAU participants were excluded because they discontinued the intervention before the final session.

Trier Social Stress Test will be utilized to induce performance anxiety through a mock job interview and mental arithmetic task conducted in front of a non-responsive committee at baseline and the final session (after 4 weeks). This test uses a standardized protocol that not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario. The social stress test not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario.

Outcome measures

Outcome measures
Measure
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Total Correct Responses on the Verbal Mental Arithmetic Task - Final Session
6.29 Responses
Standard Deviation 6.15
6.94 Responses
Standard Deviation 4.06

PRIMARY outcome

Timeframe: Final session at 4 weeks

Population: Baseline analyses included all participants, while outcome analyses included only those with complete follow-up data.

The Academic Anxiety Scale (AAS) will be used to examine performance anxiety at baseline and final session (after 4 weeks). This 11-item questionnaire uses a 4-point Likert Scale (1 = not at all typical of me to 4 = very typical of me) and measures broader aspects of academic-based anxiety beyond cognitive factors. The AAS includes items designed to assess apprehension and anxiety in academic settings, with high reliability (split-half Guttman reliability of 0.91 and Cronbach's Alpha of 0.94).

Outcome measures

Outcome measures
Measure
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Academic Anxiety at Final Session
18.94 score
Standard Deviation 6.06
19.00 score
Standard Deviation 4.83

PRIMARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

Population: Participants with at least one completed weekly check-in response for the weekly experience question.

Semi-structured interviews will be conducted during the weekly check-ins to further our understanding of the intervention's acceptability utilizing qualitative techniques such as thematic analysis.

Outcome measures

Outcome measures
Measure
Mindfulness Neurofeedback
n=16 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=17 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported a positive or acceptable overall experience
15 Participants
17 Participants
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported a technology/device challenge
8 Participants
8 Participants
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported adherence, time, or routine barriers
8 Participants
9 Participants
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported stress, illness, or life events affecting experience
9 Participants
8 Participants
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported perceived benefits such as relaxation, focus, or self-regulation
4 Participants
7 Participants

PRIMARY outcome

Timeframe: Final session at 4 weeks

Population: Baseline analyses included all participants, while outcome analyses included only those with complete follow-up data.

The Beck Anxiety Inventory (BAI) measured generalized anxiety at baseline and final session (after 4 weeks) using a 21-item Likert scale (0 to 3) to assess how distressing anxiety symptoms have been over the past week. Scores range from 0 to 63, with levels categorized as minimal (0-7), mild (8-15), moderate (16-25), and severe (30-63). The BAI has been widely used among racially diverse groups. The investigators hypothesize that BAI scores will vary significantly from pre- to post-intervention.

Outcome measures

Outcome measures
Measure
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Academic Anxiety With Beck Anxiety Inventory at Final Session
32.53 score
Standard Deviation 11.09
33.06 score
Standard Deviation 7.05

PRIMARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

Population: Participants with at least one completed weekly check-in response for the technology issue item.

Semi-structured interviews will be conducted during the weekly check-ins to further our understanding of the intervention's feasibility utilizing qualitative techniques such as thematic analysis.

Outcome measures

Outcome measures
Measure
Mindfulness Neurofeedback
n=16 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention. After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
Business as Usual
n=17 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported at least one technology issue
6 Participants
6 Participants
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported no technology issues
10 Participants
11 Participants
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Had all reported technology issues resolved
3 Participants
3 Participants
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Had at least one unresolved technology issue
3 Participants
3 Participants
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported concerns about the technology
0 Participants
0 Participants

SECONDARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

The Integrated Visual and Auditory Continuous Performance Test (IVA-2) will be used to assess attention as a secondary outcome. This computerized test measures both visual and auditory attention, providing an overall score of attentional functioning and response control. It evaluates sustained attention, impulsivity, and processing speed through a series of tasks requiring quick and accurate responses.The scores range from 0 to 145, with a mean of 100 and a standard deviation of 15. Higher scores reflect better performance. Scores of zero are valid, indicating performance 6.65 SD below average. The test includes a validity check (p \< .01) for random responses, allowing scores to be set to zero if effort was made. Rating scales are available for additional validity assessment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

The NeuroSky device will be used to measure alpha brainwave activity, a marker of relaxation and focused attention, as a secondary outcome. Mindfulness-based neurofeedback training will aim to enhance alpha activity by providing participants with real-time feedback on their brainwave patterns. During each session, participants will learn to modulate their alpha levels through mindfulness techniques, fostering a state of calm alertness. Increased alpha activity is associated with improved emotional regulation, reduced stress, and enhanced cognitive functioning. Pre- and post-intervention alpha activity levels will be compared to evaluate the effectiveness of the mindfulness-based neurofeedback training.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

The Mental Stress Assessment (MeSA) will also assess attention by measuring physiological responses during tasks designed to induce and evaluate stress-related attentional shifts.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: From enrollment to the end of treatment at 4 weeks

Heart Rate Variability (HRV) will be measured using the OptimalHRV device. We will examine HRV to determine if participants HRV increased from pre- to post-test which would be an indication of improved autonomic nervous system balance.

Outcome measures

Outcome data not reported

Adverse Events

Mindfulness Neurofeedback

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Business as Usual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Amelia Saul

Florida International University

Phone: 3053483472

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place